Concepedia

Daniela Camargo de Oliveira

DC

Statistics

Publications

6

Citations

305

H-Index

6

Active since

2018

Affiliations

Universidade Estadual de Campinas (UNICAMP)(Current)

Daniela Camargo de Oliveira is an author at Universidade Estadual de Campinas (UNICAMP) specializing in diabetes pharmacotherapy, pharmacology, and clinical pharmacology.

ORCID

Publications per year

2018–2022

6

Publications

6

Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study

Peter Langhorne, Martin O’Donnell, Siu Lim Chin et al. · The Lancet · 2018 · 140 citations · Full text

, , +14

Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial

Andrei C. Spósito, Íkaro Breder, Alexandre Soares et al. · Cardiovascular Diabetology · 2021 · 84 citations · Full text

, , +17

Association of daily physical activity with psychosocial aspects and functional capacity in patients with pulmonary arterial hypertension: a cross‐sectional study

Layse Nakazato, Felipe Augusto Rodrigues Mendes, Ilma Aparecida Paschoal et al. · Pulmonary Circulation · 2021 · 30 citations · Full text

, , +13

Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial

Andrei C. Spósito, Íkaro Breder, Joaquim Barreto et al. · Cardiovascular Diabetology · 2022 · 22 citations · Full text

, , +17

Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial

Íkaro Breder, Jessica Cunha Breder, Isabella Bonilha et al. · Therapeutic Advances in Chronic Disease · 2020 · 15 citations · Full text

, , +17

1–5 of 6